Strategic partnerships Alerje has recently secured strategic partnerships with Mgc Pure Chemicals Singapore and Mitsubishi Gas Chemical Company, indicating openness to collaboration with global players. This suggests sales opportunities in integrated allergy management solutions bundled with chemical and pharma supply chains, as well as potential co-marketing and distribution channels.

Public sector traction The United States Air Force AFWERX program engagement signals interest from government/defense sectors in emergency medicine and digital health platforms. Sales opportunities may exist in federal or military health initiatives, grant-funded pilots, and scalable deployment of allergy and overdose prevention tools.

Health tech focus Alerje operates in emergency medicine and digital health for food allergies, addressing a large unmet need among over 220 million affected individuals globally. This positions the company to target healthcare providers, hospitals, and insurance partners seeking proactive, patient-centered management tools.

Growth through healthcare channels Small team size with significant partnerships and government program involvement indicates efficiency in targeting niche channels. There is an opportunity to pursue channel partnerships with healthcare networks, pharmacy chains, and durable medical equipment suppliers to broaden adoption.

Funding and scale potential Current revenue under one million with a total funding of 3.2 million suggests room for rapid, grant-supported or partner-funded expansion. Sales focus can emphasize pilots, case studies, and ROI demonstrations to convert early-adopter customers and large-scale institutions.